MondegarAI
ACT CAPITAL MANAGEMENT, LLC

Q1 2026 · 13F-HR

ACT CAPITAL MANAGEMENT, LLCholdings as filed

Filed 2026-05-08 · accession 0001636587-26-000028

$127.2M
Reported value
56
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · ACT CAPITAL MANAGEMENT, LLC · Q1 2026

AI · grounded in 13F

ACT CAPITAL MANAGEMENT, LLC closed its position in CELCUITY INC COM MAR 20 26 $50 CALL, reducing its exposure by $3.04M. The fund established new positions in ALMS for $3.84M, FCX for $2.26M, and AAOI for $2.19M. Additionally, the manager exited holdings in GPCR, FIGR, and SPOT.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
501147102KRYSKRYSTAL BIOTECH INC$15.6M12.3%60,477CommonSOLE
166764100CVXCHEVRON CORP$15.5M12.2%75,000CommonSOLE
30231G102XOMEXXON MOBIL CORP$11.9M9.33%70,000CommonSOLE
15102K100CELCCELCUITY INC$10.5M8.22%91,675CommonSOLE
88322Q108TGTXTG THERAPEUTICS INC$8.3M6.50%249,025CommonSOLE
00370M103ABVXABIVAX SA$7.9M6.20%70,900CommonSOLE
023135106AMZNAMAZON.COM INC$6.9M5.40%33,000CommonSOLE
92686J106VKTXVIKING THERAPEUTICS INC$6.8M5.35%209,300CommonSOLE
04280A100ARWRARROWHEAD PHARMACEUTICALS INC$5.2M4.07%82,500CommonSOLE
640268306NKTRNEKTAR THERAPEUTICS$5.1M4.01%70,900CommonSOLE
23282W605CYTKCYTOKINETICS INC$4.3M3.34%64,500CommonSOLE
022307102ALMSALUMIS INC$3.8M3.02%174,250CommonSOLE
29273V100ETENERGY TRANSFER L P$2.6M2.02%133,100CommonSOLE
35671D857FCXFREEPORT-MCMORAN INC$2.3M1.78%38,500CommonSOLE
03823U102AAOIAPPLIED OPTOELECTRONICS INC$2.2M1.72%25,900CommonSOLE
98420N105XENEXENON PHARMACEUTICALS INC$1.9M1.53%33,500CommonSOLE
67080N101NUVBNUVATION BIO INC$1.2M0.98%290,000CommonSOLE
852312305STAASTAAR SURGICAL CO$1.0M0.82%55,500CommonSOLE
74006W207PRAXPRAXIS PRECISION MEDICINES INC$869,9130.68%2,700CommonSOLE
389637109GBTCGRAYSCALE BITCOIN TRUST ETF$812,5040.64%15,400CommonSOLE
81730H109SSENTINELONE INC$699,3840.55%54,300CommonSOLE
55024U109LITELUMENTUM HLDGS INC$632,4840.50%900CommonSOLE
093712107BEBLOOM ENERGY CORP$609,7050.48%4,500CommonSOLE
44952J104CRGYCRESCENT ENERGY COMPANY$607,5000.48%45,000CommonSOLE
50127T109KURAKURA ONCOLOGY INC$600,8070.47%73,900CommonSOLE
92764N102VIRVIR BIOTECHNOLOGY INC$576,1280.45%64,300CommonSOLE
172573107CRCLCIRCLE INTERNET GROUP INC$572,4600.45%6,000CommonSOLE
93627C101HCCWARRIOR MET COAL INC$558,9000.44%6,000CommonSOLE
90364P105PATHUIPATH INC$555,0000.44%50,000CommonSOLE
80706P103SRRKSCHOLAR ROCK HLDG CORP$530,9280.42%10,800CommonSOLE
81663L200WGSGENEDX HOLDINGS CORP$513,7600.40%8,000CommonSOLE
595112103MUMICRON TECHNOLOGY INC$506,7600.40%1,500CommonSOLE
67066G104NVDANVIDIA CORPORATION$488,3200.38%2,800CommonSOLE
76029N106REPLREPLIMUNE GROUP INC$470,4750.37%61,500CommonSOLE
75901B107RGNXREGENXBIO INC$469,2800.37%56,000CommonSOLE
696389402PALIPALISADE BIO INC$450,6250.35%257,500CommonSOLE
68062P106OLMAOLEMA PHARMACEUTICALS INC$372,7500.29%25,000CommonSOLE
61225M102GLUEMONTE ROSA THERAPEUTICS INC$370,1250.29%22,500CommonSOLE
68236H204ONDSONDAS INC$339,0000.27%37,500CommonSOLE
02074J501ACOGALPHA COGNITION INC$282,7350.22%51,500CommonSOLE
55287L101MBXMBX BIOSCIENCES INC$268,6500.21%9,000CommonSOLE
04124A100APCARKO PETE CORP$268,3500.21%15,000CommonSOLE
501976104KYTXKYVERNA THERAPEUTICS INC$258,9000.20%30,000CommonSOLE
783754104RYZRYERSON HOLDING CORP$242,7840.19%10,800CommonSOLE
N85083108NKLRTERRA INNOVATUM GLOBAL NV$208,8000.16%45,000CommonSOLE
45337C102INCYINCYTE CORP$188,2400.15%2,000CommonSOLE
14070B309CAPRCAPRICOR THERAPEUTICS INC$152,0000.12%5,000CommonSOLE
92835K103VPGVISHAY PRECISION GROUP INC$130,2600.10%3,000CommonSOLE
29664W105ESPRESPERION THERAPEUTICS INC$130,1500.10%47,500CommonSOLE
03237H101AMLXAMYLYX PHARMACEUTICALS INC$125,1000.10%9,000CommonSOLE
53229C107LSPDLIGHTSPEED COMMERCE INC$112,0000.09%12,500CommonSOLE
20451W101CMPSCOMPASS PATHWAYS PLC$85,7150.07%15,500CommonSOLE
516548203LTRXLANTRONIX INC$78,6000.06%15,000CommonSOLE
M85548101SSYSSTRATASYS LTD$78,1000.06%10,000CommonSOLE
433000106HIMSHIMS &HERS HEALTH INC$51,9000.04%2,500CommonSOLE
70465T107PDSBPDS BIOTECHNOLOGY CORP$18,1500.01%30,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.